72 results on '"Seo, Hyemyung"'
Search Results
2. Generation of a human iPSC line from a Parkinson’s disease patient with a novel CHCHD2 mutation (R145Q)
3. Multicomponent Metal-Organic Framework Nanocomposites for Tumor-Responsive Synergistic Therapy
4. Spotting-based differentiation of functional dopaminergic progenitors from human pluripotent stem cells
5. Analysis of multi‐omics data on the relationship between epigenetic changes and nervous system disorders caused by exposure to environmentally harmful substances
6. Matrix Metalloproteinase-8 Inhibitor Ameliorates Inflammatory Responses and Behavioral Deficits in LRRK2 G2019S Parkinson's Disease Model Mice
7. Dysfunction of X-linked inhibitor of apoptosis protein (XIAP) triggers neuropathological processes via altered p53 activity in Huntington’s disease
8. Brain cells derived from Alzheimer’s disease patients have multiple specific innate abnormalities in energy metabolism
9. Modulation of SETDB1 activity by APQ ameliorates heterochromatin condensation, motor function, and neuropathology in a Huntington’s disease mouse model
10. Iroquois Homeobox Protein 2 Identified as a Potential Biomarker for Parkinson’s Disease
11. Personalized iPSC-Derived Dopamine Progenitor Cells for Parkinson’s Disease
12. Transcriptional Regulation of the Dopamine β-Hydroxylase Gene
13. Human autologous iPSC–derived dopaminergic progenitors restore motor function in Parkinson’s disease models
14. Differential phosphorylation of cytoskeletal proteins in LRRK2 R1441G Parkinson's disease model
15. Dysfunction of X-linked inhibitor of apoptosis protein (XIAP) leads to neuronal damage via altered p53 activity in Huntington's disease
16. Target screening of miR126 in pathological process of Alzheimer's disease
17. The effects of histone deacetylase inhibition on neuroinflammation and motor control in LRRK2 R1441G mice
18. HDAC Inhibition by Valproic Acid Induces Neuroprotection and Improvement of PD-like Behaviors in LRRK2 R1441G Transgenic Mice
19. Increase in anti-apoptotic molecules, nucleolin, and heat shock protein 70, against upregulated LRRK2 kinase activity
20. Cell-Penetrating Peptide-Patchy Deformable Polymeric Nanovehicles with Enhanced Cellular Uptake and Transdermal Delivery
21. Oxidized DJ-1 Levels in Urine Samples as a Putative Biomarker for Parkinson’s Disease
22. Age-associated bimodal transcriptional drift reduces intergenic disparities in transcription
23. Suppression of neuroinflammation by matrix metalloproteinase-8 inhibitor in aged normal and LRRK2 G2019S Parkinson's disease model mice challenged with lipopolysaccharide
24. Correction to: Leucine-Rich Repeat Kinase 2 (LRRK2) phosphorylates p53 and induces p21WAF1/CIP1 expression
25. Age-associated chromatin relaxation is enhanced in Huntington’s disease mice
26. Alpha-Synuclein Suppresses Retinoic Acid-Induced Neuronal Differentiation by Targeting the Glycogen Synthase Kinase-3β/β-Catenin Signaling Pathway
27. Leucine-rich repeat kinase 2 exacerbates neuronal cytotoxicity through phosphorylation of histone deacetylase 3 and histone deacetylation
28. β-Lapachone increases phase II antioxidant enzyme expression via NQO1-AMPK/PI3K-Nrf2/ARE signaling in rat primary astrocytes
29. G2385R and I2020T Mutations Increase LRRK2 GTPase Activity
30. Leucine-Rich Repeat Kinase 2 (LRRK2) phosphorylates p53 and induces p21WAF1/CIP1 expression
31. LRRK2 G2019S mutation attenuates microglial motility by inhibiting focal adhesion kinase
32. Enhancement of BACE1 Activity by p25/Cdk5-Mediated Phosphorylation in Alzheimer’s Disease
33. Increased TRPC5 glutathionylation contributes to striatal neuron loss in Huntington’s disease
34. Reduction of Nfia gene expression and subsequent target genes by binge alcohol in the fetal brain
35. Neuroanatomical Visualization of the Impaired Striatal Connectivity in Huntington’s Disease Mouse Model
36. Extracellular Vesicles and Neurological Diseases
37. An early endosome regulator, Rab5b, is an LRRK2 kinase substrate
38. MiR-126 Regulates Growth Factor Activities and Vulnerability to Toxic Insult in Neurons
39. JMJD2A attenuation affects cell cycle and tumourigenic inflammatory gene regulation in lipopolysaccharide stimulated neuroectodermal stem cells
40. Prediction of miRNA-mRNA associations in Alzheimer’s disease mice using network topology
41. miR-126 contributes to Parkinson's disease by dysregulating the insulin-like growth factor/phosphoinositide 3-kinase signaling
42. Systemic injection of LPS induces region-specific neuroinflammation and mitochondrial dysfunction in normal mouse brain
43. Baclofen, a GABAB receptor agonist, enhances ubiquitin-proteasome system functioning and neuronal survival in Huntington’s disease model mice
44. Increased DJ-1 in Urine Exosome of Korean Males with Parkinson’s Disease
45. Development of Electrochemical Microbiochip for the Biological Diagnosis of Neisseria gonorrhoeae
46. EPITRANS: A database that integrates epigenome and transcriptome data
47. LRRK2 phosphorylates Snapin and inhibits interaction of Snapin with SNAP-25
48. Identification of cancer-specific biomarkers by using microarray gene expression profiling
49. Pharmacological Rescue of Mitochondrial Deficits in iPSC-Derived Neural Cells from Patients with Familial Parkinson’s Disease
50. P3-186: The effect of VPA in presymptomatic Alzheimer's disease model mice
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.